However, Recursion’s revenue significantly underperformed, coming in at $5.18 million compared to the expected $16.95 million. This revenue shortfall marks a substantial miss for the company.

Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Rana Coniglio, an Arizona-based therapist who works primarily with Gen Z clients, said they often arrive at her practice ...

Some algorithms solve problems. This one changed civilization. From guiding satellites to securing your bank account, its influence reaches every corner of technology. It started with a simple insight ...

Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

Indian mathematician Srinivasa Ramanujan’s formula for Pi can help with calculating black holes, studying percolation, or ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...